CD163 and cancer: Interestingly, there is evidence of a correlation between the presence of CD163-expressing macrophages and more aggressive growth across various types of cancer suggesting that the presence of higher numbers of CD163 immunoreactive macrophages is indicative of a poor prognosis [12–15].